Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 Omicron variants BA.1 and BA.2 both show similarly reduced disease severity of COVID-19 compared to Delta, Germany, 2021 to 2022
Claudia Sievers, Benedikt Zacher, Alexander Ullrich, et al.
Eurosurveillance (2022) Vol. 27, Iss. 22
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England
Matthew Whitaker, Joshua Elliott, Barbara Bodinier, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 113
Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa
Nicole Wolter, Waasila Jassat, Sibongile Walaza, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 86
Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 66
SARS-CoV-2 variants evolve convergent strategies to remodel the host response
Mehdi Bouhaddou, Ann‐Kathrin Reuschl, Benjamin J. Polacco, et al.
Cell (2023) Vol. 186, Iss. 21, pp. 4597-4614.e26
Open Access | Times Cited: 65
Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019–positive patients
Feihong Hu, Yijie Jia, Dan‐Yan Zhao, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 7, pp. 835-844
Open Access | Times Cited: 56
Reinfection rate and disease severity of the BA.5 Omicron SARS-CoV-2 lineage compared to previously circulating variants of concern in the Canary Islands (Spain)
Laura Ciuffreda, José M. Lorenzo-Salazar, Diego García-Martínez de Artola, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 24
The emergence of SARS-CoV-2 Omicron subvariants: current situation and future trends
Ramadan Abdelmoez Farahat, Abdelaziz Abdelaal, Tungki Pratama Umar, et al.
Infezioni in Medicina (2022) Vol. 30, Iss. 4
Open Access | Times Cited: 30
Characteristics and outcomes of COVID-19 patients during B.1.1.529 (Omicron) dominance compared to B.1.617.2 (Delta) in 89 German hospitals
Johannes Leiner, Vincent Pellissier, Sven Hohenstein, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 29
An ultrasensitive ELISA to assay femtomolar level SARS-CoV-2 antigen based on specific peptide and tyramine signal amplification
Junchong Liu, Shuang Pang, Mingyang Wang, et al.
Sensors and Actuators B Chemical (2023) Vol. 387, pp. 133746-133746
Open Access | Times Cited: 20
Evolution of Omicron lineage towards increased fitness in the upper respiratory tract in the absence of severe lung pathology
Arthur Wickenhagen, Meaghan Flagg, Julia R. Port, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Variants on Inpatient Clinical Outcome
Matthew L. Robinson, C. Paul Morris, Joshua Betz, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 9, pp. 1539-1549
Open Access | Times Cited: 25
Trends in Cases, Hospitalizations, and Mortality Related to the Omicron BA.4/BA.5 Subvariants in South Africa
Waasila Jassat, Salim S. Abdool Karim, Lovelyn Ozougwu, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 8, pp. 1468-1475
Open Access | Times Cited: 23
Omicron BA.2 Lineage, the “Stealth” Variant: Is It Truly a Silent Epidemic? A Literature Review
Giorgio Tiecco, Samuele Storti, Stefania Arsuffi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7315-7315
Open Access | Times Cited: 22
Comparison of the clinical characteristics of SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) infected patients from a single hospitalist service
N. Radhakrishnan, Min Liu, Bukunmi Michael Idowu, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Epidemiology of healthcare-associated SARS-CoV-2 outbreaks in Germany between March 2020 and May 2022
Beneditta Suwono, Michael Brandl, Jochen Hecht, et al.
Journal of Hospital Infection (2023) Vol. 134, pp. 108-120
Open Access | Times Cited: 13
Clinical Manifestations of Infections with the Omicron Sub-Lineages BA.1, BA.2, and BA.5: A Retrospective Follow-Up Analysis of Public Health Data from Mecklenburg-Western Pomerania, Germany
Katja V. Goller, Janine Ziemann, Christian Köhler, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 454-454
Open Access | Times Cited: 4
The real-time infection hospitalisation and fatality risk across the COVID-19 pandemic in England
Thomas Ward, Martyn Fyles, Alex Glaser, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Comparative hospitalization risk for SARS‐CoV‐2 Omicron and Delta variant infections, by variant predominance periods and patient‐level sequencing results, New York City, August 2021–January 2022
Sharon K. Greene, Alison Levin‐Rector, Nang Thu Thu Kyaw, et al.
Influenza and Other Respiratory Viruses (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 19
Projecting the future impact of emerging SARS-CoV-2 variants under uncertainty: Modeling the initial Omicron outbreak
Sean M. Moore, Sean Cavany, T. Alex Perkins, et al.
Epidemics (2024) Vol. 47, pp. 100759-100759
Open Access | Times Cited: 3
The Impact and Progression of the COVID-19 Pandemic in Bulgaria in Its First Two Years
Antoni Rangachev, Georgi K. Marinov, Младен Младенов
Vaccines (2022) Vol. 10, Iss. 11, pp. 1901-1901
Open Access | Times Cited: 16
Changing Epidemiology of COVID-19 in Children and Adolescents Over Four Successive Epidemic Waves in South Africa, 2020–2022
Nicola Chiwandire, Waasila Jassat, Michelle J. Groome, et al.
Journal of the Pediatric Infectious Diseases Society (2023) Vol. 12, Iss. 3, pp. 128-134
Open Access | Times Cited: 9
COVID-19 Severity and Mortality in Two Pandemic Waves in Poland and Predictors of Poor Outcomes of SARS-CoV-2 Infection in Hospitalized Young Adults
Laura Ziuzia-Januszewska, Marcin Januszewski, Joanna Sosnowska-Nowak, et al.
Viruses (2022) Vol. 14, Iss. 8, pp. 1700-1700
Open Access | Times Cited: 14
Could the New BA.2.75 Sub-Variant Cause the Emergence of a Global Epidemic of COVID-19? A Scoping Review
Nour Shaheen, Abdelrahman Mohamed, Almoatazbellah Attalla, et al.
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 6317-6330
Open Access | Times Cited: 14
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April–December 2021 in Italy
Alessia Lai, Annalisa Bergna, Carla Della Ventura, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2508-2508
Open Access | Times Cited: 14
Association of SARS-CoV-2 Nucleocapsid Protein Mutations with Patient Demographic and Clinical Characteristics during the Delta and Omicron Waves
Feda A. Alsuwairi, Asma N. Alsaleh, Madain S. Alsanea, et al.
Microorganisms (2023) Vol. 11, Iss. 5, pp. 1288-1288
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top